
Company valuation, historical trends, and peer comparisons.
According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.71B. This represents a change of 68.46% compared to the average of 5.76B of the last 4 quarters.
The mean historical Enterprise Value of TG Therapeutics, Inc. over the last ten years is 2.26B. The current 9.71B Enterprise Value has changed 330.07% with respect to the historical average. Over the past ten years (40 quarters), TGTX's Enterprise Value was at its highest in in the June 2026 quarter at 8.06B. The Enterprise Value was at its lowest in in the December 2016 quarter at 204.18M.
Average
2.26B
Median
1.94B
Minimum
203.08M
Maximum
5.49B
Discovering the peaks and valleys of TG Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 503.72%
Maximum Annual Enterprise Value = 5.49B
Minimum Annual Increase = -58.53%
Minimum Annual Enterprise Value = 203.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 4.48B | 0.80% |
| 2024 | 4.45B | 82.11% |
| 2023 | 2.44B | 54.32% |
| 2022 | 1.58B | -30.96% |
| 2021 | 2.29B | -58.23% |
| 2020 | 5.49B | 503.72% |
| 2019 | 909.06M | 239.81% |
| 2018 | 267.52M | -40.86% |
| 2017 | 452.38M | 122.76% |
| 2016 | 203.08M | -58.53% |
The current Enterprise Value of TG Therapeutics, Inc. (TGTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.79B
5-year avg
3.05B
10-year avg
2.26B
TG Therapeutics, Inc.’s Enterprise Value is less than Genmab A/S (36.89B), greater than Xencor, Inc. (2.61B), greater than Celldex Therapeutics, Inc. (2.31B), greater than MacroGenics, Inc. (68.33M), greater than ADC Therapeutics S.A. (417.59M), greater than Corvus Pharmaceuticals, Inc. (870.98M), greater than Innate Pharma S.A. (131.50M), greater than Adagene Inc. (-31089611.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 36.89B | $33.89B | |
| 2.61B | $2.60B | |
| 2.31B | $2.35B | |
| 68.33M | $147.15M | |
| 417.59M | $219.59M | |
| 870.98M | $889.16M | |
| 131.50M | $159.17M | |
| -31089611.00 | $90.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is TG Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for TG Therapeutics, Inc. (TGTX)?
What is the 3-year average Enterprise Value for TG Therapeutics, Inc. (TGTX)?
What is the 5-year average Enterprise Value for TG Therapeutics, Inc. (TGTX)?
How does the current Enterprise Value for TG Therapeutics, Inc. (TGTX) compare to its historical average?